| In vivo imaging of neuromelanin in Parkinson’s disease using 18 F-AV-1451 PET AK Hansen, K Knudsen, TP Lillethorup, AM Landau, P Parbo, T Fedorova, ... Brain 139 (7), 2039-2049, 2016 | 132 | 2016 |
| Fas—beyond death: a regenerative role for Fas in the nervous system C Lambert, AM Landau, J Desbarats Apoptosis 8, 551-562, 2003 | 120 | 2003 |
| Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson’s disease JA Phan, K Stokholm, J Zareba-Paslawska, S Jakobsen, K Vang, ... Scientific reports 7 (1), 6363, 2017 | 85 | 2017 |
| Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease AM Landau, KC Luk, ML Jones, R Siegrist-Johnstone, YK Young, ... The Journal of experimental medicine 202 (5), 575-581, 2005 | 74 | 2005 |
| [11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates L Kuebler, S Buss, A Leonov, S Ryazanov, F Schmidt, A Maurer, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 1759-1772, 2021 | 67 | 2021 |
| Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates AM Landau, MM Chakravarty, CM Clark, AP Zis, DJ Doudet Neuropsychopharmacology 36 (2), 511-518, 2011 | 63 | 2011 |
| PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats MB Thomsen, SA Ferreira, AC Schacht, J Jacobsen, M Simonsen, ... Neurobiology of disease 149, 105229, 2021 | 56 | 2021 |
| Serotonergic modulation of receptor occupancy in rats treated with l‐DOPA after unilateral 6‐OHDA lesioning A Nahimi, M Høltzermann, AM Landau, M Simonsen, S Jakobsen, ... Journal of neurochemistry 120 (5), 806-817, 2012 | 53 | 2012 |
| Synaptic vesicle glycoprotein 2A: features and functions R Rossi, S Arjmand, SL Bærentzen, A Gjedde, AM Landau Frontiers in neuroscience 16, 864514, 2022 | 49 | 2022 |
| Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD A Kirkeby, J Nelander, DB Hoban, N Rogelius, H Bjartmarz, P Storm, ... Cell Stem Cell 30 (10), 1299-1314. e9, 2023 | 42 | 2023 |
| Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain M Winterdahl, O Noer, D Orlowski, AC Schacht, S Jakobsen, AKO Alstrup, ... Scientific reports 9 (1), 16918, 2019 | 42 | 2019 |
| Acute vagal nerve stimulation lowers α2 adrenoceptor availability: possible mechanism of therapeutic action AM Landau, S Dyve, S Jakobsen, AKO Alstrup, A Gjedde, DJ Doudet Brain stimulation 8 (4), 702-707, 2015 | 41 | 2015 |
| In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C] UCB-J PET MB Thomsen, J Jacobsen, TP Lillethorup, AC Schacht, M Simonsen, ... Journal of Cerebral Blood Flow & Metabolism 41 (4), 819-830, 2021 | 35 | 2021 |
| A genetically modified minipig model for Alzheimer’s disease with SORL1 haploinsufficiency OM Andersen, N Bøgh, AM Landau, GG Pløen, AMG Jensen, G Monti, ... Cell Reports Medicine 3 (9), 2022 | 34 | 2022 |
| Glucagon-like peptide-1 analog, liraglutide, delays onset of experimental autoimmune encephalitis in lewis rats B DellaValle, GS Brix, B Brock, M Gejl, AM Landau, A Møller, J Rungby, ... Frontiers in Pharmacology 7, 433, 2016 | 33 | 2016 |
| Increased inflammation and unchanged density of synaptic vesicle glycoprotein 2A (SV2A) in the postmortem frontal cortex of Alzheimer’s disease patients A Metaxas, C Thygesen, SRR Briting, AM Landau, S Darvesh, B Finsen Frontiers in cellular neuroscience 13, 538, 2019 | 31 | 2019 |
| Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease A Metaxas, C Thygesen, SJ Kempf, M Anzalone, R Vaitheeswaran, ... Scientific Reports 9 (1), 15758, 2019 | 31 | 2019 |
| Effects of anesthesia and species on the uptake or binding of radioligands in vivo in the Göttingen minipig AKO Alstrup, AM Landau, JE Holden, S Jakobsen, AC Schacht, H Audrain, ... BioMed research international 2013 (1), 808713, 2013 | 31 | 2013 |
| Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease A Metaxas, M Anzalone, R Vaitheeswaran, S Petersen, AM Landau, ... Alzheimer's research & therapy 11, 1-13, 2019 | 30 | 2019 |
| Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs TP Lillethorup, AN Glud, AKO Alstrup, TW Mikkelsen, EH Nielsen, H Zaer, ... Experimental Neurology 303, 142-152, 2018 | 30 | 2018 |
